LOGICMARK INC (LGMK)

US67091J5039 - Common Stock

2.0644  -0.07 (-3.08%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to LGMK. LGMK was compared to 188 industry peers in the Health Care Equipment & Supplies industry. LGMK scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. LGMK has a expensive valuation and it also scores bad on growth.



1

1. Profitability

1.1 Basic Checks

In the past year LGMK has reported negative net income.
LGMK had a negative operating cash flow in the past year.
In the past 5 years LGMK always reported negative net income.
In the past 5 years LGMK always reported negative operating cash flow.

1.2 Ratios

With a Return On Assets value of -115.61%, LGMK is not doing good in the industry: 85.03% of the companies in the same industry are doing better.
The Return On Equity of LGMK (-131.35%) is worse than 72.73% of its industry peers.
Industry RankSector Rank
ROA -115.61%
ROE -131.35%
ROIC N/A
ROA(3y)-55.89%
ROA(5y)-45.83%
ROE(3y)-62.38%
ROE(5y)-72.24%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

LGMK has a Gross Margin of 66.93%. This is in the better half of the industry: LGMK outperforms 72.19% of its industry peers.
In the last couple of years the Gross Margin of LGMK has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for LGMK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 66.93%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.19%
GM growth 5Y-1.39%

6

2. Health

2.1 Basic Checks

LGMK does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for LGMK has been increased compared to 1 year ago.
Compared to 5 years ago, LGMK has more shares outstanding
There is no outstanding debt for LGMK. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

LGMK has an Altman-Z score of -6.84. This is a bad value and indicates that LGMK is not financially healthy and even has some risk of bankruptcy.
LGMK has a worse Altman-Z score (-6.84) than 71.12% of its industry peers.
LGMK has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -6.84
ROIC/WACCN/A
WACC9.03%

2.3 Liquidity

A Current Ratio of 2.78 indicates that LGMK has no problem at all paying its short term obligations.
LGMK has a Current ratio (2.78) which is in line with its industry peers.
A Quick Ratio of 2.36 indicates that LGMK has no problem at all paying its short term obligations.
LGMK has a Quick ratio (2.36) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 2.78
Quick Ratio 2.36

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 36.14% over the past year.
Looking at the last year, LGMK shows a decrease in Revenue. The Revenue has decreased by -2.94% in the last year.
LGMK shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -10.32% yearly.
EPS 1Y (TTM)36.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%47.27%
Revenue 1Y (TTM)-2.94%
Revenue growth 3Y-4.62%
Revenue growth 5Y-10.32%
Sales Q2Q%0.39%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y67.28%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-1.7%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LGMK. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for LGMK. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

LGMK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

LOGICMARK INC

NASDAQ:LGMK (11/21/2024, 2:48:54 PM)

2.0644

-0.07 (-3.08%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap12.53M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -115.61%
ROE -131.35%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 66.93%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.73
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 2.78
Quick Ratio 2.36
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)36.14%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y67.28%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-2.94%
Revenue growth 3Y-4.62%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y